Related Experiment Video
Updated: Jul 14, 2026

11:49
Synthesis of Soft Polysiloxane-urea Elastomers for Intraocular Lens Application
Published on: March 8, 2019
New intraocular lens for achromatizing the human eye
Norberto López-Gil1, Robert Montés-Micó
1CiVi-UM, University of Murcia, Murcia, Spain.
Journal of Cataract and Refractive Surgery
|June 26, 2007
Summary
A new hybrid singlet achromatic intraocular lens (IOL) corrects spherical and chromatic aberrations. This innovative IOL design enhances overall optical quality in the human eye.
Area of Science:
- Ophthalmic optics
- Optical engineering
- Visual science
Background:
- Spherical and chromatic aberrations impact visual quality after intraocular lens (IOL) implantation.
- Existing IOLs often struggle to fully correct these optical aberrations.
- Advancements in IOL design are crucial for improving patient visual outcomes.
Purpose of the Study:
- To design a novel hybrid singlet achromatic intraocular lens (IOL).
- To evaluate the IOL's capability in correcting both spherical and chromatic aberrations.
- To assess the impact of the IOL on overall optical quality in pseudophakic eyes.
Main Methods:
- A hybrid singlet achromatic IOL was designed, incorporating refractive and diffractive surfaces.
- Aspherical surface design was utilized in one of the IOL surfaces.
- Optical simulations modeled the polychromatic modulation transfer function (MTF) to assess optical quality.
Main Results:
- The designed achromatic IOL achieved near diffraction-limited polychromatic MTF when centered and not tilted.
- Focus shift across the visible spectrum was minimal, approximately 0.1 diopters.
- The IOL demonstrated robustness to tilt and decentration, maintaining optical benefits within clinically relevant ranges.
Conclusions:
- The hybrid singlet achromatic IOL design effectively addresses chromatic aberration.
- This novel IOL design significantly improves the overall optical quality in the human eye.
- The design offers a promising solution for enhanced visual performance in pseudophakic patients.
Related Concept Videos
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

